Filing Details

Accession Number:
0001209191-20-047804
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-20 18:36:55
Reporting Period:
2020-08-18
Accepted Time:
2020-08-20 18:36:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1708493 Harpoon Therapeutics Inc. HARP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557930 Georgia Erbez C/O Harpoon Therapeutics, Inc.
131 Oyster Point Boulevard, Suite 300
South San Francisco CA 94080
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-18 2,098 $11.60 3,915 No 4 P Indirect See footnote
Common Stock Acquisiton 2020-08-19 5,000 $11.40 8,915 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 47,292 Direct
Common Stock 6,700 Indirect See footnote
Footnotes
  1. Shares indirectly held by Georgia Leigh Erbez Charles Schwab & Co Inc Cust IRA Contributory ("Georgia Erbez IRA Contributory"). The Reporting Person has beneficial ownership over these shares held by Georgia Erbez IRA Contributory.
  2. Shares indirectly held by David Milan Erbez Charles Schwab & Co Inc Cust IRA Contributory ("David Erbez IRA Contributory"). The Reporting Person has beneficial ownership over these shares held by David Erbez IRA Contributory.